August 04, 2025 a 03:43 pm
DXCM: Fundamental Ratio Analysis - DexCom, Inc.
DexCom, Inc. is prominently known for its innovative continuous glucose monitoring systems. With robust partnerships and a strong international presence, the company has been making significant strides in the healthcare technology sector. However, while it maintains a positive trajectory, investors should consider the challenges in the competitive landscape of medical devices.
Fundamental Rating
The fundamental ratings for DexCom suggest a mixed but stable outlook with key emphasis on its return metrics.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 5 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
A glance at historical ratings provides insights into the consistency in overall scoring.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-01 | 3 | 3 | 5 | 4 | 1 | 1 | 1 |
| Previous Date | 0 | 3 | 5 | 4 | 1 | 1 | 1 |
Analysts' Price Targets
DexCom's stock exhibits potential with diversified analyst forecasts on price targets and consensus ratings.
| High | Low | Median | Consensus |
|---|---|---|---|
| 146 | 28.125 | 95 | 81.36 |
Analysts' Opinion
The overall sentiment from analysts shows positive endorsement of DexCom with the following recommendation breakdown.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 36 | |
| Hold | 11 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
DexCom, Inc. stands as a pivotal player in the CGM systems market with commendable growth reflected in its stock ratings. The strong buy-in from analysts showcases market confidence despite the high innovation requirements of the medical device industry. Potential investors should consider the company's strategic partnerships and advancements. However, mindful attention is necessary due to its volatility in debt-to-equity and earnings ratios. DexCom remains an intriguing possibility for stakeholders prioritizing technological advancement and market position.